N. Yamada et al., TREATMENT OF SYMPTOMATIC HEPATIC CYSTS BY PERCUTANEOUS INSTILLATION OF MINOCYCLINE HYDROCHLORIDE, Digestive diseases and sciences, 39(11), 1994, pp. 2503-2509
Nine patients with 16 symptomatic nonneoplastic congenital hepatic cys
ts were treated prospectively by ultrasonically guided percutaneous mi
nocycline hydrochloride injection, and the usefulness of this treatmen
t was evaluated. Seven of the patients had multiple hepatic cysts, and
two solitary cysts. Ail the patients were women, ranging in age from
36 to 81 years. After cystic fluid had been aspirated with a 21-gauge
PTC needle, minocycline hydrochloride was injected into all the cysts.
The minocycline hydrochloride was dissolved in saline at a concentrat
ion of 200 mg in 9 mi, and mixed with 1 mi of 2% mepivacaine hydrochlo
ride. The total quantity of minocycline hydrochloride injected varied
from 100 mg to 1200 mg per hepatic cyst, depending on its size. Total
or subtotal regression of the cysts was observed in all patients durin
g follow-up periods ranging from 15 to 35 months. Seven patients becam
e symptom-free, one showed symptom reduction, and one showed no change
in symptoms. Minor side effects, eg, transient abdominal pain, slight
right shoulder pain, and temperature elevation, were noted in three p
atients respectively. On the basis of these results, we conclude that
ultrasonically guided percutaneous minocycline hydrochloride injection
is useful for the treatment of symptomatic hepatic cysts.